Huang James's Form 4 filing
Atara Biotherapeutics, Inc. (ATRA) · filed Jul 21, 2025
- Accession no.
- 0000950170-25-097087
- Filed
- Jul 21, 2025, 9:00 AM ET
- Trade date
- Jul 17, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $186.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huang JamesCIK 0001573160 | Director, 10% Owner |
| Panacea Innovation LtdCIK 0002010692 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | Common Stock | PPurchaseAcquired | +19,335 | $9.64 | +$186,372 | 1,350,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.